UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Escalation for Bivariate Binary Endpoints Controlling the Risk of Overtoxicity (EBE-CRO): Managing Efficacy and Toxicity in Early Oncology Clinical Trials

Journal of biopharmaceutical statistics, 2017-11, Vol.27 (6), p.1054-1072

2017

Volltextzugriff (PDF)

Efficacy of alirocumab in heterozygous familial hypercholesterolemia or high cv risk populations: pooled analyses of eight phase 3 trials

Atherosclerosis, 2015-07, Vol.241 (1), p.e25-e26

2015

Volltextzugriff (PDF)

Efficacy of alirocumab according to background statin intensity and other lipid-lowering therapy in heterozygous familial hypercholesterolemia or high cv risk populations: phase 3 sub-group analyses

Atherosclerosis, 2015-07, Vol.241 (1), p.e21-e21

2015

Volltextzugriff (PDF)

Relation between heart rate variability and training load in middle-distance runners

Medicine and science in sports and exercise, 2000-10, Vol.32 (10), p.1729-1736

2000

Volltextzugriff (PDF)

P363 The AMETHIST phase 3 trial of venglustat in patients with GM2 gangliosidoses and related diseases: baseline characteristics

Neuromuscular disorders : NMD, 2023-10, Vol.33, p.S186-S186

2023

Volltextzugriff (PDF)

OTHER NMDs

Neuromuscular disorders : NMD, 2021-10, Vol.31, p.S157

2021

Volltextzugriff (PDF)

OTHER NMDs: EP.352 Venglustat, a novel brain-penetrant glucosylceramide synthase inhibitor, for GM2 gangliosidosis and related diseases: Phase 3 AMETHIST trial design

Neuromuscular disorders : NMD, 2021-10, Vol.31, p.S157-S157

2021

Volltextzugriff (PDF)

Sensitivity analysis of longitudinal binary data with non-monotone missing values

Biostatistics (Oxford, England), 2004-10, Vol.5 (4), p.531-544

2004

Volltextzugriff (PDF)

An escalation for bivariate binary endpoints controlling the risk of overtoxicity (EBE-CRO ): managing efficacy and toxicity in early oncologyvClinical trials

Journal of biopharmaceutical statistics, 2017, Vol.27 (6), p.1-19

2017

Volltextzugriff (PDF)

Screening of obstructive sleep apnea syndrome by heart rate variability analysis

Circulation (New York, N.Y.), 1999-09, Vol.100 (13), p.1411-1415

1999

Volltextzugriff (PDF)

Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma

Pediatrics (Evanston), 2003-06, Vol.111 (6 Pt 1), p.e706-e713

2003

Volltextzugriff (PDF)

Sensitivity analysis of longitudinal normal data with drop-outs

Statistics in medicine, 2004-04, Vol.23 (7), p.1039-1054

2004

Volltextzugriff (PDF)

Modelling and analysis of incomplete and short lactations

Animal science (Penicuik, Scotland), 2003-02, Vol.76 (1), p.19-25

2003

Volltextzugriff (PDF)

Analyse de données binaires répétées : sensibilité aux données manquantes

Revue d'épidémiologie et de santé publique, 2004-10, Vol.52 (5), p.455-464

2004

Volltextzugriff (PDF)

Elevated nocturnal blood pressure assessed by ambulatory automatic monitoring during a stay at high altitude

European Journal of Applied Physiology and Occupational Physiology, 1995-03, Vol.70 (3), p.258-262, Article 258

1995

Volltextzugriff (PDF)

A practical method to statistically classify devices according to their relative accuracy

Clinical physiology (Oxford), 2001-03, Vol.21 (2), p.214-222

2001

Volltextzugriff (PDF)

Multiplicity of inferences in clinical trials: adjustment methods, clinical interpretation issues

M.S. Médecine sciences, 2004-02, Vol.20 (2), p.231-235

2004

Volltextzugriff (PDF)

Analysis of repeated binary data: sensitivity to missing data

Revue d'épidémiologie et de santé publique, 2004-10, Vol.52 (5), p.455-464

2004

Volltextzugriff (PDF)

Maximal blood lactate level acts as a major discriminant variable in exercise testing for coronary artery disease detection in men

Circulation (New York, N.Y.), 1996-01, Vol.93 (2), p.246-252

1996

Volltextzugriff (PDF)

Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)

Annals of intensive care, 2020-05, Vol.10 (1), p.64-64, Article 64

2020

Volltextzugriff (PDF)

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials

Atherosclerosis, 2019-09, Vol.288, p.194-202

2019

Volltextzugriff (PDF)

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control

Circulation (New York, N.Y.), 2016-12, Vol.134 (24), p.1931-1943

2016

Volltextzugriff (PDF)

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia

Journal of clinical lipidology, 2017-01, Vol.11 (1), p.195-203.e4

2017

Volltextzugriff (PDF)

A study to evaluate the effect of venglustat on neuropathic and abdominal pain in symptomatic adult patients with Fabry disease

Molecular genetics and metabolism, 2022-02, Vol.135 (2), p.S56-S57

2022

Volltextzugriff (PDF)

Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial

American journal of kidney diseases, 2023-05, Vol.81 (5), p.517-527.e1

2023

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(45)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An Escalation for Bivariate Binary Endpoints Controlling the Risk of Overtoxicity (EBE-CRO): Managing Efficacy and Toxicity in Early Oncology Clinical Trials

Efficacy of alirocumab in heterozygous familial hypercholesterolemia or high cv risk populations: pooled analyses of eight phase 3 trials

Efficacy of alirocumab according to background statin intensity and other lipid-lowering therapy in heterozygous familial hypercholesterolemia or high cv risk populations: phase 3 sub-group analyses

Relation between heart rate variability and training load in middle-distance runners

P363 The AMETHIST phase 3 trial of venglustat in patients with GM2 gangliosidoses and related diseases: baseline characteristics

OTHER NMDs

OTHER NMDs: EP.352 Venglustat, a novel brain-penetrant glucosylceramide synthase inhibitor, for GM2 gangliosidosis and related diseases: Phase 3 AMETHIST trial design

Sensitivity analysis of longitudinal binary data with non-monotone missing values

An escalation for bivariate binary endpoints controlling the risk of overtoxicity (EBE-CRO ): managing efficacy and toxicity in early oncologyvClinical trials

Screening of obstructive sleep apnea syndrome by heart rate variability analysis

Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma

Sensitivity analysis of longitudinal normal data with drop-outs

Modelling and analysis of incomplete and short lactations

Analyse de données binaires répétées : sensibilité aux données manquantes

Elevated nocturnal blood pressure assessed by ambulatory automatic monitoring during a stay at high altitude

A practical method to statistically classify devices according to their relative accuracy

Multiplicity of inferences in clinical trials: adjustment methods, clinical interpretation issues

Analysis of repeated binary data: sensitivity to missing data

Maximal blood lactate level acts as a major discriminant variable in exercise testing for coronary artery disease detection in men

Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)

Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials

Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial hypercholesterolemia

A study to evaluate the effect of venglustat on neuropathic and abdominal pain in symptomatic adult patients with Fabry disease

Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial

Suchergebnisse filtern